Animal model development and efficacy testing

Ended Awarded Last action

Contract number
75N93021F00002
Awardee
Awarding agency
Obligated
$11,164,074

Award facts

Contract value 100% obligated
$11,164,073.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Menlo Park, CA 94025, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 -$16,453
Other Administrative Action P00008 · Animal model development and efficacy testing of candidate mcms $117,936
Funding Only Action P00007 · To administrate DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 -$117,936
Other Administrative Action P00006 $0
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $11,180,527

About this award

The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 30, 2021, with a ceiling value of $11.2 million for animal model development and efficacy testing of candidate medical countermeasures.

Place of performance is Menlo Park, CA. Ultimate completion date is September 29, 2026. The order is priced on a cost-plus-fixed-fee basis with no set-aside.

Service Contract Inventory reporting shows the order has invoiced $10.6 million across FY2022–FY2025. FY2022 activity was modest at 3.5 FTEs and 7,311 contractor hours ($511 thousand); activity ramped significantly in FY2023–FY2024, reaching 8.8 FTEs and 18,246 contractor hours ($4.8 million in FY2024). FY2025 contracted to 1.2 FTEs and 2,554 contractor hours ($1.2 million), reflecting a wind-down posture ahead of the September 2026 completion date. Government-paid blended hourly rates rose across the period—$69.88/hr (FY2022) to $477.82/hr (FY2025)—indicating a shift toward higher-skill labor or increased subcontractor utilization. In FY2025, one subcontractor performed 35 percent of contractor hours.

Quick answers

Who was awarded contract 75N93021F00002?

75N93021F00002 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2021.

How much is contract 75N93021F00002 worth?

The government has obligated $11,164,074 on 75N93021F00002.

Is contract 75N93021F00002 an order under another contract?

Yes. 75N93021F00002 is a delivery order under 75N93020D00011, an indefinite delivery contract.

Was contract 75N93021F00002 competed?

The extent of competition for 75N93021F00002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award